N/A
N=507
Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03337399 ↗Enrolled (actual)
507
Serious AEs
—
Results posted
Sep 2024
Primary outcome: Primary: Patient-reported Quality of Life — 100.62; 97.75 score on a scale — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Stepped PC (Other); Early Integrated PC (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient-reported Quality of Life |
100.62; 97.75 | <0.05 sig |
| SECONDARY Proportion of Patients Who Self-report Discussing Their End of Life Care Preferences With Their Clinicians |
58; 62 | <0.15 |
| SECONDARY Length of Stay in Hospice |
19.5; 34.6 | 0.15 |
| SECONDARY Palliative Care Resource Utilization |
2.4; 4.7 | 0.15 |
Summary
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Eligibility Criteria
Inclusion Criteria
- Diagnosed with advanced non-small cell lung cancer, small cell lung cancer, or mesothelioma, being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks
- Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 2 (symptomatic and in bed 18 years
Exclusion Criteria
- Already receiving outpatient PC or hospice services
- Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation
Data sourced from ClinicalTrials.gov (NCT03337399). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.